Indian pharma group has eyes on Da Nang

Update: 11:25 | 30/07/2021
A group of 30 pharmaceutical production companies from India plans to build the first Pharma Park in Viet Nam, and Da Nang city’s Hi-tech Park has been suggested as a prime location.
Indian pharma group has eyes on Da Nang
Factories are developing at the Da Nang IT Park. The city has been calling for investment from India to build the first pharmaceutical production centre in Da Nang. (Photo: Anh Huy)

The Indian business group, which accounts for a 30 per cent share of Indian exports, expects to build a pharmaceutical production centre and fill the shortage of material and medicines supplying Viet Nam’s pharmaceutical production chains.

Vice-chairman of the municipal People’s Committee Ho Ky Minh said the city’s 1,184ha hi-tech park infrastructure has been flagged as a potential site for the first Pharma Park in Viet Nam.

He said the park would be a magnet for Indian pharma firms and producers as it offers flexible land rent, land clearance, and favourable income tax and import tax policies including land rent exemption for the first three years of operation.

Under the Prime Minister’s decision signed in 2018, investors in traffic, technical infrastructure and public works, or special investment projects will enjoy a land-rent exemption for the entire duration of their investment period in the park.

Investors will be given incentives as they benefit from a 10 percent tax rate for 15 years, a four-year tax exemption and a 50 per cent cut in income tax for the following nine years, he said.

He added that projects valued at more than 133 million USD will get a 10 per cent tax rate for 30 years, while businesses will have to pay no import tax on materials and equipment that are not available in Viet Nam for the first five years of operation.

Minh said the city’s education system with 106 universities, colleges and vocational centres supplies 25,000 students each year, while nearly 10,000 doctors, nurses and medical staff are working at 22 hospitals.

The Indian pharma producers group has its own manufacturing centre in Visakhapatnam, and a series of companies including Hospira healthcare, Hetero pharmaceutical company, Shasun pharmaceuticals, Natco Pharma and Eisai Pharmaceuticals.

Da Nang Hi-tech Park, which was designed as a ‘green’ hub in central Viet Nam, offers a number of benefits to manufacturers.

This includes Lien Chieu seaport, Kim Lien railway station and logistics centre, an airport and a national highway all within a radius of 20km.

It also smoothly connects with the Chan May Economic Zone in Thua Thien-Hue, the Chu Lai Economic Open Zone in Quang Nam and Dung Quat Economic Zone in Quang Ngai province, Minh said.

The park’s authorities have granted an investment licence to the local Danapha Pharmaceutical Joint Stock Company for developing the first nano-technology and biotech project with an investment capital of 1.5 trillion VND (67 million USD).

Up-to-date, Da Nang has attracted 905 foreign direct investment (FDI) projects worth 3.85 billion USD, with the hi-tech park alone a destination for 24 of those projects with a total of 815 million USD.

TIN LIÊN QUAN
Electricity corporation, Singaporean group to sign strategic cooperation agreement
PM Pham Minh Chinh holds phone talks with Indian counterpart
Viet Nam-co-initiated Group of Friends on UNCLOS debuts in New York
Viet Nam in Group B of World Cup qualifiers’ third round
VCCI proposes working group to tackle container shortages

(Source: VNA)